IN FOCUS: Solvias
Pharmaceutical Technology
DECEMBER 9, 2022
Solvias has extensive experience with analytical method development and testing for mRNA-based vaccines as well as monograph testing of excipients and APIs according to Ph Eur or USP. All our equipment is in line with the latest European Medicines Agency (EMA) and FDA methods. Assays to support mRNA-based Covid-19 vaccines.
Let's personalize your content